gene_id,pathway_count,pathway_ids,pathway_names,databases
ALK,16,GO_Biological_Process_2023:Positive Regulation Of Transferase Activity (GO:0051347);GO_Biological_Process_2023:Positive Regulation Of Phosphorylation (GO:0042327);GO_Biological_Process_2023:Positive Regulation Of Kinase Activity (GO:0033674);GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);GO_Biological_Process_2023:Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167);GO_Biological_Process_2023:Regulation Of Apoptotic Process (GO:0042981);GO_Biological_Process_2023:Peptidyl-Tyrosine Phosphorylation (GO:0018108);GO_Biological_Process_2023:Neuron Differentiation (GO:0030182);GO_Biological_Process_2023:Phosphorylation (GO:0016310);GO_Biological_Process_2023:Protein Phosphorylation (GO:0006468);GO_Molecular_Function_2023:Transmembrane Receptor Protein Kinase Activity (GO:0019199);GO_Molecular_Function_2023:Protein Tyrosine Kinase Activity (GO:0004713);KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:PD-L1 expression and PD-1 checkpoint pathway in cancer,Positive Regulation Of Transferase Activity (GO:0051347);Positive Regulation Of Phosphorylation (GO:0042327);Positive Regulation Of Kinase Activity (GO:0033674);Regulation Of Cell Population Proliferation (GO:0042127);Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167);Regulation Of Apoptotic Process (GO:0042981);Peptidyl-Tyrosine Phosphorylation (GO:0018108);Neuron Differentiation (GO:0030182);Phosphorylation (GO:0016310);Protein Phosphorylation (GO:0006468);Transmembrane Receptor Protein Kinase Activity (GO:0019199);Protein Tyrosine Kinase Activity (GO:0004713);Non-small cell lung cancer;Pathways in cancer;PD-L1 expression and PD-1 checkpoint pathway in cancer,GO_Biological_Process_2023;GO_Molecular_Function_2023;KEGG_2021_Human
MYC,55,GO_Biological_Process_2023:Positive Regulation Of Transferase Activity (GO:0051347);GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Response To Ionizing Radiation (GO:0010212);GO_Biological_Process_2023:Negative Regulation Of Apoptotic Process (GO:0043066);GO_Biological_Process_2023:Negative Regulation Of Programmed Cell Death (GO:0043069);GO_Biological_Process_2023:Regulation Of Epithelial Cell Proliferation (GO:0050678);GO_Biological_Process_2023:Branching Morphogenesis Of An Epithelial Tube (GO:0048754);GO_Biological_Process_2023:Regulation Of Apoptotic Process (GO:0042981);GO_Biological_Process_2023:Regulation Of Cell Cycle (GO:0051726);GO_Biological_Process_2023:Positive Regulation Of miRNA Transcription (GO:1902895);GO_Biological_Process_2023:Regulation Of Fibroblast Proliferation (GO:0048145);GO_Biological_Process_2023:Positive Regulation Of miRNA Metabolic Process (GO:2000630);GO_Biological_Process_2023:Positive Regulation Of Epithelial Cell Proliferation (GO:0050679);GO_Biological_Process_2023:Positive Regulation Of Gene Expression (GO:0010628);GO_Biological_Process_2023:Positive Regulation Of Cell Population Proliferation (GO:0008284);GO_Biological_Process_2023:Regulation Of miRNA Transcription (GO:1902893);GO_Biological_Process_2023:Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);GO_Biological_Process_2023:Negative Regulation Of Cellular Process (GO:0048523);GO_Biological_Process_2023:Cellular Response To Hypoxia (GO:0071456);GO_Biological_Process_2023:Cellular Response To Decreased Oxygen Levels (GO:0036294);GO_Biological_Process_2023:Positive Regulation Of Cellular Process (GO:0048522);GO_Biological_Process_2023:MAPK Cascade (GO:0000165);GO_Biological_Process_2023:Response To UV (GO:0009411);GO_Biological_Process_2023:Positive Regulation Of DNA Metabolic Process (GO:0051054);KEGG_2021_Human:Bladder cancer;KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Endometrial cancer;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Gastric cancer;KEGG_2021_Human:Central carbon metabolism in cancer;KEGG_2021_Human:Chronic myeloid leukemia;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:Colorectal cancer;KEGG_2021_Human:PI3K-Akt signaling pathway;KEGG_2021_Human:Proteoglycans in cancer;KEGG_2021_Human:Human cytomegalovirus infection;KEGG_2021_Human:Cellular senescence;KEGG_2021_Human:Hepatitis C;KEGG_2021_Human:ErbB signaling pathway;KEGG_2021_Human:Human T-cell leukemia virus 1 infection;KEGG_2021_Human:Small cell lung cancer;KEGG_2021_Human:Kaposi sarcoma-associated herpesvirus infection;KEGG_2021_Human:MAPK signaling pathway;KEGG_2021_Human:Thyroid cancer;KEGG_2021_Human:Hepatitis B;KEGG_2021_Human:Cell cycle;KEGG_2021_Human:Acute myeloid leukemia;KEGG_2021_Human:Chemical carcinogenesis;KEGG_2021_Human:Epstein-Barr virus infection;KEGG_2021_Human:Thyroid hormone signaling pathway;KEGG_2021_Human:Signaling pathways regulating pluripotency of stem cells;KEGG_2021_Human:JAK-STAT signaling pathway;KEGG_2021_Human:Wnt signaling pathway;KEGG_2021_Human:Transcriptional misregulation in cancer,Positive Regulation Of Transferase Activity (GO:0051347);Regulation Of Cell Population Proliferation (GO:0042127);Response To Ionizing Radiation (GO:0010212);Negative Regulation Of Apoptotic Process (GO:0043066);Negative Regulation Of Programmed Cell Death (GO:0043069);Regulation Of Epithelial Cell Proliferation (GO:0050678);Branching Morphogenesis Of An Epithelial Tube (GO:0048754);Regulation Of Apoptotic Process (GO:0042981);Regulation Of Cell Cycle (GO:0051726);Positive Regulation Of miRNA Transcription (GO:1902895);Regulation Of Fibroblast Proliferation (GO:0048145);Positive Regulation Of miRNA Metabolic Process (GO:2000630);Positive Regulation Of Epithelial Cell Proliferation (GO:0050679);Positive Regulation Of Gene Expression (GO:0010628);Positive Regulation Of Cell Population Proliferation (GO:0008284);Regulation Of miRNA Transcription (GO:1902893);Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);Negative Regulation Of Cellular Process (GO:0048523);Cellular Response To Hypoxia (GO:0071456);Cellular Response To Decreased Oxygen Levels (GO:0036294);Positive Regulation Of Cellular Process (GO:0048522);MAPK Cascade (GO:0000165);Response To UV (GO:0009411);Positive Regulation Of DNA Metabolic Process (GO:0051054);Bladder cancer;Breast cancer;Hepatocellular carcinoma;Endometrial cancer;Pathways in cancer;Gastric cancer;Central carbon metabolism in cancer;Chronic myeloid leukemia;MicroRNAs in cancer;Colorectal cancer;PI3K-Akt signaling pathway;Proteoglycans in cancer;Human cytomegalovirus infection;Cellular senescence;Hepatitis C;ErbB signaling pathway;Human T-cell leukemia virus 1 infection;Small cell lung cancer;Kaposi sarcoma-associated herpesvirus infection;MAPK signaling pathway;Thyroid cancer;Hepatitis B;Cell cycle;Acute myeloid leukemia;Chemical carcinogenesis;Epstein-Barr virus infection;Thyroid hormone signaling pathway;Signaling pathways regulating pluripotency of stem cells;JAK-STAT signaling pathway;Wnt signaling pathway;Transcriptional misregulation in cancer,GO_Biological_Process_2023;KEGG_2021_Human
ERBB2,52,GO_Biological_Process_2023:Positive Regulation Of Transferase Activity (GO:0051347);GO_Biological_Process_2023:Regulation Of Cell Growth (GO:0001558);GO_Biological_Process_2023:Regulation Of Kinase Activity (GO:0043549);GO_Biological_Process_2023:Positive Regulation Of Phosphorylation (GO:0042327);GO_Biological_Process_2023:Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173);GO_Biological_Process_2023:Positive Regulation Of Kinase Activity (GO:0033674);GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);GO_Biological_Process_2023:Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167);GO_Biological_Process_2023:Negative Regulation Of Apoptotic Process (GO:0043066);GO_Biological_Process_2023:Phosphatidylinositol 3-Kinase Signaling (GO:0014065);GO_Biological_Process_2023:Negative Regulation Of Programmed Cell Death (GO:0043069);GO_Biological_Process_2023:Regulation Of Epithelial Cell Proliferation (GO:0050678);GO_Biological_Process_2023:Regulation Of Apoptotic Process (GO:0042981);GO_Biological_Process_2023:Positive Regulation Of Epithelial Cell Proliferation (GO:0050679);GO_Biological_Process_2023:Positive Regulation Of Gene Expression (GO:0010628);GO_Biological_Process_2023:Positive Regulation Of Cell Population Proliferation (GO:0008284);GO_Biological_Process_2023:Phosphatidylinositol-Mediated Signaling (GO:0048015);GO_Biological_Process_2023:Regulation Of ERK1 And ERK2 Cascade (GO:0070372);GO_Biological_Process_2023:Positive Regulation Of Protein Phosphorylation (GO:0001934);GO_Biological_Process_2023:Peptidyl-Tyrosine Phosphorylation (GO:0018108);GO_Biological_Process_2023:Regulation Of Protein Phosphorylation (GO:0001932);GO_Biological_Process_2023:Neuron Differentiation (GO:0030182);GO_Biological_Process_2023:Phosphorylation (GO:0016310);GO_Biological_Process_2023:Nervous System Development (GO:0007399);GO_Biological_Process_2023:Positive Regulation Of Cellular Process (GO:0048522);GO_Biological_Process_2023:Positive Regulation Of MAP Kinase Activity (GO:0043406);GO_Biological_Process_2023:Protein Phosphorylation (GO:0006468);GO_Biological_Process_2023:Positive Regulation Of Protein Modification Process (GO:0031401);GO_Biological_Process_2023:Regulation Of MAP Kinase Activity (GO:0043405);GO_Biological_Process_2023:Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902);GO_Molecular_Function_2023:Transmembrane Receptor Protein Kinase Activity (GO:0019199);GO_Molecular_Function_2023:Protein Tyrosine Kinase Activity (GO:0004713);GO_Molecular_Function_2023:Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0004714);KEGG_2021_Human:Bladder cancer;KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Endometrial cancer;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Gastric cancer;KEGG_2021_Human:Central carbon metabolism in cancer;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:Prostate cancer;KEGG_2021_Human:PI3K-Akt signaling pathway;KEGG_2021_Human:Proteoglycans in cancer;KEGG_2021_Human:ErbB signaling pathway;KEGG_2021_Human:Focal adhesion;KEGG_2021_Human:MAPK signaling pathway;KEGG_2021_Human:HIF-1 signaling pathway;KEGG_2021_Human:Adherens junction;KEGG_2021_Human:Calcium signaling pathway,Positive Regulation Of Transferase Activity (GO:0051347);Regulation Of Cell Growth (GO:0001558);Regulation Of Kinase Activity (GO:0043549);Positive Regulation Of Phosphorylation (GO:0042327);Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173);Positive Regulation Of Kinase Activity (GO:0033674);Regulation Of Cell Population Proliferation (GO:0042127);Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167);Negative Regulation Of Apoptotic Process (GO:0043066);Phosphatidylinositol 3-Kinase Signaling (GO:0014065);Negative Regulation Of Programmed Cell Death (GO:0043069);Regulation Of Epithelial Cell Proliferation (GO:0050678);Regulation Of Apoptotic Process (GO:0042981);Positive Regulation Of Epithelial Cell Proliferation (GO:0050679);Positive Regulation Of Gene Expression (GO:0010628);Positive Regulation Of Cell Population Proliferation (GO:0008284);Phosphatidylinositol-Mediated Signaling (GO:0048015);Regulation Of ERK1 And ERK2 Cascade (GO:0070372);Positive Regulation Of Protein Phosphorylation (GO:0001934);Peptidyl-Tyrosine Phosphorylation (GO:0018108);Regulation Of Protein Phosphorylation (GO:0001932);Neuron Differentiation (GO:0030182);Phosphorylation (GO:0016310);Nervous System Development (GO:0007399);Positive Regulation Of Cellular Process (GO:0048522);Positive Regulation Of MAP Kinase Activity (GO:0043406);Protein Phosphorylation (GO:0006468);Positive Regulation Of Protein Modification Process (GO:0031401);Regulation Of MAP Kinase Activity (GO:0043405);Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902);Transmembrane Receptor Protein Kinase Activity (GO:0019199);Protein Tyrosine Kinase Activity (GO:0004713);Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0004714);Bladder cancer;Non-small cell lung cancer;Pancreatic cancer;Breast cancer;Endometrial cancer;Pathways in cancer;Gastric cancer;Central carbon metabolism in cancer;MicroRNAs in cancer;Prostate cancer;PI3K-Akt signaling pathway;Proteoglycans in cancer;ErbB signaling pathway;Focal adhesion;MAPK signaling pathway;HIF-1 signaling pathway;Adherens junction;Calcium signaling pathway,GO_Biological_Process_2023;GO_Molecular_Function_2023;KEGG_2021_Human
MET,31,GO_Biological_Process_2023:Positive Regulation Of Transferase Activity (GO:0051347);GO_Biological_Process_2023:Regulation Of Kinase Activity (GO:0043549);GO_Biological_Process_2023:Positive Regulation Of Phosphorylation (GO:0042327);GO_Biological_Process_2023:Positive Regulation Of Kinase Activity (GO:0033674);GO_Biological_Process_2023:Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);GO_Biological_Process_2023:Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167);GO_Biological_Process_2023:Negative Regulation Of Programmed Cell Death (GO:0043069);GO_Biological_Process_2023:Branching Morphogenesis Of An Epithelial Tube (GO:0048754);GO_Biological_Process_2023:Neuron Differentiation (GO:0030182);GO_Biological_Process_2023:Nervous System Development (GO:0007399);GO_Molecular_Function_2023:Protein Tyrosine Kinase Activity (GO:0004713);GO_Molecular_Function_2023:Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0004714);GO_Molecular_Function_2023:Protein Phosphatase Binding (GO:0019903);KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Melanoma;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Gastric cancer;KEGG_2021_Human:Central carbon metabolism in cancer;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:PI3K-Akt signaling pathway;KEGG_2021_Human:Proteoglycans in cancer;KEGG_2021_Human:Renal cell carcinoma;KEGG_2021_Human:Focal adhesion;KEGG_2021_Human:MAPK signaling pathway;KEGG_2021_Human:Rap1 signaling pathway;KEGG_2021_Human:Ras signaling pathway;KEGG_2021_Human:Adherens junction;KEGG_2021_Human:Calcium signaling pathway;KEGG_2021_Human:Axon guidance;KEGG_2021_Human:Transcriptional misregulation in cancer,Positive Regulation Of Transferase Activity (GO:0051347);Regulation Of Kinase Activity (GO:0043549);Positive Regulation Of Phosphorylation (GO:0042327);Positive Regulation Of Kinase Activity (GO:0033674);Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167);Negative Regulation Of Programmed Cell Death (GO:0043069);Branching Morphogenesis Of An Epithelial Tube (GO:0048754);Neuron Differentiation (GO:0030182);Nervous System Development (GO:0007399);Protein Tyrosine Kinase Activity (GO:0004713);Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0004714);Protein Phosphatase Binding (GO:0019903);Non-small cell lung cancer;Melanoma;Hepatocellular carcinoma;Pathways in cancer;Gastric cancer;Central carbon metabolism in cancer;MicroRNAs in cancer;PI3K-Akt signaling pathway;Proteoglycans in cancer;Renal cell carcinoma;Focal adhesion;MAPK signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Adherens junction;Calcium signaling pathway;Axon guidance;Transcriptional misregulation in cancer,GO_Biological_Process_2023;GO_Molecular_Function_2023;KEGG_2021_Human
ROS1,14,GO_Biological_Process_2023:Positive Regulation Of Transferase Activity (GO:0051347);GO_Biological_Process_2023:Regulation Of Cell Growth (GO:0001558);GO_Biological_Process_2023:Regulation Of Kinase Activity (GO:0043549);GO_Biological_Process_2023:Positive Regulation Of Phosphorylation (GO:0042327);GO_Biological_Process_2023:Positive Regulation Of Kinase Activity (GO:0033674);GO_Biological_Process_2023:Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);GO_Biological_Process_2023:Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167);GO_Biological_Process_2023:Regulation Of ERK1 And ERK2 Cascade (GO:0070372);GO_Biological_Process_2023:Phosphorylation (GO:0016310);GO_Biological_Process_2023:Protein Phosphorylation (GO:0006468);GO_Molecular_Function_2023:Transmembrane Receptor Protein Kinase Activity (GO:0019199);GO_Molecular_Function_2023:Protein Tyrosine Kinase Activity (GO:0004713);GO_Molecular_Function_2023:Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0004714);GO_Molecular_Function_2023:Protein Phosphatase Binding (GO:0019903),Positive Regulation Of Transferase Activity (GO:0051347);Regulation Of Cell Growth (GO:0001558);Regulation Of Kinase Activity (GO:0043549);Positive Regulation Of Phosphorylation (GO:0042327);Positive Regulation Of Kinase Activity (GO:0033674);Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167);Regulation Of ERK1 And ERK2 Cascade (GO:0070372);Phosphorylation (GO:0016310);Protein Phosphorylation (GO:0006468);Transmembrane Receptor Protein Kinase Activity (GO:0019199);Protein Tyrosine Kinase Activity (GO:0004713);Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0004714);Protein Phosphatase Binding (GO:0019903),GO_Biological_Process_2023;GO_Molecular_Function_2023
EGFR,82,GO_Biological_Process_2023:Positive Regulation Of Transferase Activity (GO:0051347);GO_Biological_Process_2023:Regulation Of Cell Growth (GO:0001558);GO_Biological_Process_2023:Regulation Of Kinase Activity (GO:0043549);GO_Biological_Process_2023:Positive Regulation Of Phosphorylation (GO:0042327);GO_Biological_Process_2023:Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173);GO_Biological_Process_2023:Positive Regulation Of Kinase Activity (GO:0033674);GO_Biological_Process_2023:Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045);GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);GO_Biological_Process_2023:Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167);GO_Biological_Process_2023:Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079);GO_Biological_Process_2023:Negative Regulation Of Apoptotic Process (GO:0043066);GO_Biological_Process_2023:Negative Regulation Of Programmed Cell Death (GO:0043069);GO_Biological_Process_2023:Regulation Of Epithelial Cell Proliferation (GO:0050678);GO_Biological_Process_2023:Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135);GO_Biological_Process_2023:Regulation Of Apoptotic Process (GO:0042981);GO_Biological_Process_2023:Positive Regulation Of miRNA Transcription (GO:1902895);GO_Biological_Process_2023:Positive Regulation Of miRNA Metabolic Process (GO:2000630);GO_Biological_Process_2023:Positive Regulation Of Epithelial Cell Proliferation (GO:0050679);GO_Biological_Process_2023:ERBB Signaling Pathway (GO:0038127);GO_Biological_Process_2023:Positive Regulation Of Cell Population Proliferation (GO:0008284);GO_Biological_Process_2023:Regulation Of miRNA Transcription (GO:1902893);GO_Biological_Process_2023:Regulation Of ERK1 And ERK2 Cascade (GO:0070372);GO_Biological_Process_2023:Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992);GO_Biological_Process_2023:Positive Regulation Of Protein Phosphorylation (GO:0001934);GO_Biological_Process_2023:Peptidyl-Tyrosine Phosphorylation (GO:0018108);GO_Biological_Process_2023:Regulation Of Protein Phosphorylation (GO:0001932);GO_Biological_Process_2023:Nervous System Development (GO:0007399);GO_Biological_Process_2023:Positive Regulation Of Cellular Process (GO:0048522);GO_Biological_Process_2023:Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138);GO_Biological_Process_2023:Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730);GO_Biological_Process_2023:Positive Regulation Of MAP Kinase Activity (GO:0043406);GO_Biological_Process_2023:Response To UV (GO:0009411);GO_Biological_Process_2023:Protein Phosphorylation (GO:0006468);GO_Biological_Process_2023:Positive Regulation Of DNA Metabolic Process (GO:0051054);GO_Biological_Process_2023:Positive Regulation Of Protein Modification Process (GO:0031401);GO_Biological_Process_2023:Regulation Of MAP Kinase Activity (GO:0043405);GO_Biological_Process_2023:Negative Regulation Of Multicellular Organismal Process (GO:0051241);GO_Biological_Process_2023:Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902);GO_Molecular_Function_2023:Transmembrane Receptor Protein Kinase Activity (GO:0019199);GO_Molecular_Function_2023:Protein Tyrosine Kinase Activity (GO:0004713);GO_Molecular_Function_2023:Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0004714);GO_Molecular_Function_2023:Protein Phosphatase Binding (GO:0019903);GO_Molecular_Function_2023:Ubiquitin Protein Ligase Binding (GO:0031625);GO_Molecular_Function_2023:Ubiquitin-Like Protein Ligase Binding (GO:0044389);KEGG_2021_Human:Bladder cancer;KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Melanoma;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Endometrial cancer;KEGG_2021_Human:Glioma;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Gastric cancer;KEGG_2021_Human:Central carbon metabolism in cancer;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:Prostate cancer;KEGG_2021_Human:Colorectal cancer;KEGG_2021_Human:PI3K-Akt signaling pathway;KEGG_2021_Human:Proteoglycans in cancer;KEGG_2021_Human:Human cytomegalovirus infection;KEGG_2021_Human:Hepatitis C;KEGG_2021_Human:ErbB signaling pathway;KEGG_2021_Human:PD-L1 expression and PD-1 checkpoint pathway in cancer;KEGG_2021_Human:Human papillomavirus infection;KEGG_2021_Human:Focal adhesion;KEGG_2021_Human:MAPK signaling pathway;KEGG_2021_Human:Cushing syndrome;KEGG_2021_Human:Rap1 signaling pathway;KEGG_2021_Human:FoxO signaling pathway;KEGG_2021_Human:Chemical carcinogenesis;KEGG_2021_Human:HIF-1 signaling pathway;KEGG_2021_Human:Regulation of actin cytoskeleton;KEGG_2021_Human:Relaxin signaling pathway;KEGG_2021_Human:Ras signaling pathway;KEGG_2021_Human:Adherens junction;KEGG_2021_Human:Choline metabolism in cancer;KEGG_2021_Human:Calcium signaling pathway;KEGG_2021_Human:Estrogen signaling pathway;KEGG_2021_Human:Phospholipase D signaling pathway;KEGG_2021_Human:JAK-STAT signaling pathway,Positive Regulation Of Transferase Activity (GO:0051347);Regulation Of Cell Growth (GO:0001558);Regulation Of Kinase Activity (GO:0043549);Positive Regulation Of Phosphorylation (GO:0042327);Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173);Positive Regulation Of Kinase Activity (GO:0033674);Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045);Regulation Of Cell Population Proliferation (GO:0042127);Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167);Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079);Negative Regulation Of Apoptotic Process (GO:0043066);Negative Regulation Of Programmed Cell Death (GO:0043069);Regulation Of Epithelial Cell Proliferation (GO:0050678);Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135);Regulation Of Apoptotic Process (GO:0042981);Positive Regulation Of miRNA Transcription (GO:1902895);Positive Regulation Of miRNA Metabolic Process (GO:2000630);Positive Regulation Of Epithelial Cell Proliferation (GO:0050679);ERBB Signaling Pathway (GO:0038127);Positive Regulation Of Cell Population Proliferation (GO:0008284);Regulation Of miRNA Transcription (GO:1902893);Regulation Of ERK1 And ERK2 Cascade (GO:0070372);Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992);Positive Regulation Of Protein Phosphorylation (GO:0001934);Peptidyl-Tyrosine Phosphorylation (GO:0018108);Regulation Of Protein Phosphorylation (GO:0001932);Nervous System Development (GO:0007399);Positive Regulation Of Cellular Process (GO:0048522);Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138);Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730);Positive Regulation Of MAP Kinase Activity (GO:0043406);Response To UV (GO:0009411);Protein Phosphorylation (GO:0006468);Positive Regulation Of DNA Metabolic Process (GO:0051054);Positive Regulation Of Protein Modification Process (GO:0031401);Regulation Of MAP Kinase Activity (GO:0043405);Negative Regulation Of Multicellular Organismal Process (GO:0051241);Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902);Transmembrane Receptor Protein Kinase Activity (GO:0019199);Protein Tyrosine Kinase Activity (GO:0004713);Transmembrane Receptor Protein Tyrosine Kinase Activity (GO:0004714);Protein Phosphatase Binding (GO:0019903);Ubiquitin Protein Ligase Binding (GO:0031625);Ubiquitin-Like Protein Ligase Binding (GO:0044389);Bladder cancer;Non-small cell lung cancer;Pancreatic cancer;Breast cancer;Melanoma;Hepatocellular carcinoma;Endometrial cancer;Glioma;Pathways in cancer;Gastric cancer;Central carbon metabolism in cancer;MicroRNAs in cancer;Prostate cancer;Colorectal cancer;PI3K-Akt signaling pathway;Proteoglycans in cancer;Human cytomegalovirus infection;Hepatitis C;ErbB signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;Human papillomavirus infection;Focal adhesion;MAPK signaling pathway;Cushing syndrome;Rap1 signaling pathway;FoxO signaling pathway;Chemical carcinogenesis;HIF-1 signaling pathway;Regulation of actin cytoskeleton;Relaxin signaling pathway;Ras signaling pathway;Adherens junction;Choline metabolism in cancer;Calcium signaling pathway;Estrogen signaling pathway;Phospholipase D signaling pathway;JAK-STAT signaling pathway,GO_Biological_Process_2023;GO_Molecular_Function_2023;KEGG_2021_Human
RB1,43,GO_Biological_Process_2023:Regulation Of Cell Growth (GO:0001558);GO_Biological_Process_2023:Regulation Of Kinase Activity (GO:0043549);GO_Biological_Process_2023:Negative Regulation Of Cell Cycle (GO:0045786);GO_Biological_Process_2023:Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045);GO_Biological_Process_2023:Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901);GO_Biological_Process_2023:Negative Regulation Of Apoptotic Process (GO:0043066);GO_Biological_Process_2023:Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134);GO_Biological_Process_2023:Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807);GO_Biological_Process_2023:Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991);GO_Biological_Process_2023:Regulation Of Cell Cycle (GO:0051726);GO_Biological_Process_2023:Small GTPase Mediated Signal Transduction (GO:0007264);GO_Biological_Process_2023:Negative Regulation Of Cell Growth (GO:0030308);GO_Biological_Process_2023:Negative Regulation Of Growth (GO:0045926);GO_Biological_Process_2023:Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992);GO_Biological_Process_2023:Ras Protein Signal Transduction (GO:0007265);GO_Biological_Process_2023:Negative Regulation Of Cellular Process (GO:0048523);GO_Biological_Process_2023:Negative Regulation Of Multicellular Organismal Process (GO:0051241);GO_Molecular_Function_2023:Ubiquitin Protein Ligase Binding (GO:0031625);GO_Molecular_Function_2023:Ubiquitin-Like Protein Ligase Binding (GO:0044389);KEGG_2021_Human:Bladder cancer;KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Melanoma;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Glioma;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Gastric cancer;KEGG_2021_Human:Chronic myeloid leukemia;KEGG_2021_Human:Prostate cancer;KEGG_2021_Human:Human cytomegalovirus infection;KEGG_2021_Human:Cellular senescence;KEGG_2021_Human:Hepatitis C;KEGG_2021_Human:Human T-cell leukemia virus 1 infection;KEGG_2021_Human:Small cell lung cancer;KEGG_2021_Human:Human papillomavirus infection;KEGG_2021_Human:Kaposi sarcoma-associated herpesvirus infection;KEGG_2021_Human:Cushing syndrome;KEGG_2021_Human:Hepatitis B;KEGG_2021_Human:Viral carcinogenesis;KEGG_2021_Human:Cell cycle;KEGG_2021_Human:Chemical carcinogenesis;KEGG_2021_Human:Epstein-Barr virus infection,Regulation Of Cell Growth (GO:0001558);Regulation Of Kinase Activity (GO:0043549);Negative Regulation Of Cell Cycle (GO:0045786);Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045);Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901);Negative Regulation Of Apoptotic Process (GO:0043066);Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134);Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807);Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991);Regulation Of Cell Cycle (GO:0051726);Small GTPase Mediated Signal Transduction (GO:0007264);Negative Regulation Of Cell Growth (GO:0030308);Negative Regulation Of Growth (GO:0045926);Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992);Ras Protein Signal Transduction (GO:0007265);Negative Regulation Of Cellular Process (GO:0048523);Negative Regulation Of Multicellular Organismal Process (GO:0051241);Ubiquitin Protein Ligase Binding (GO:0031625);Ubiquitin-Like Protein Ligase Binding (GO:0044389);Bladder cancer;Non-small cell lung cancer;Pancreatic cancer;Breast cancer;Melanoma;Hepatocellular carcinoma;Glioma;Pathways in cancer;Gastric cancer;Chronic myeloid leukemia;Prostate cancer;Human cytomegalovirus infection;Cellular senescence;Hepatitis C;Human T-cell leukemia virus 1 infection;Small cell lung cancer;Human papillomavirus infection;Kaposi sarcoma-associated herpesvirus infection;Cushing syndrome;Hepatitis B;Viral carcinogenesis;Cell cycle;Chemical carcinogenesis;Epstein-Barr virus infection,GO_Biological_Process_2023;GO_Molecular_Function_2023;KEGG_2021_Human
CDKN2A,29,GO_Biological_Process_2023:Regulation Of Cell Growth (GO:0001558);GO_Biological_Process_2023:Negative Regulation Of Cell Cycle (GO:0045786);GO_Biological_Process_2023:Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045);GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079);GO_Biological_Process_2023:Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901);GO_Biological_Process_2023:Regulation Of Cell Cycle (GO:0051726);GO_Biological_Process_2023:Small GTPase Mediated Signal Transduction (GO:0007264);GO_Biological_Process_2023:Negative Regulation Of Cell Growth (GO:0030308);GO_Biological_Process_2023:Negative Regulation Of Growth (GO:0045926);GO_Biological_Process_2023:Ras Protein Signal Transduction (GO:0007265);GO_Biological_Process_2023:Negative Regulation Of Cellular Process (GO:0048523);GO_Biological_Process_2023:Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806);KEGG_2021_Human:Bladder cancer;KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Melanoma;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Glioma;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Chronic myeloid leukemia;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:Human cytomegalovirus infection;KEGG_2021_Human:Cellular senescence;KEGG_2021_Human:Human T-cell leukemia virus 1 infection;KEGG_2021_Human:Cushing syndrome;KEGG_2021_Human:Viral carcinogenesis;KEGG_2021_Human:Cell cycle;KEGG_2021_Human:p53 signaling pathway,Regulation Of Cell Growth (GO:0001558);Negative Regulation Of Cell Cycle (GO:0045786);Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045);Regulation Of Cell Population Proliferation (GO:0042127);Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079);Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901);Regulation Of Cell Cycle (GO:0051726);Small GTPase Mediated Signal Transduction (GO:0007264);Negative Regulation Of Cell Growth (GO:0030308);Negative Regulation Of Growth (GO:0045926);Ras Protein Signal Transduction (GO:0007265);Negative Regulation Of Cellular Process (GO:0048523);Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806);Bladder cancer;Non-small cell lung cancer;Pancreatic cancer;Melanoma;Hepatocellular carcinoma;Glioma;Pathways in cancer;Chronic myeloid leukemia;MicroRNAs in cancer;Human cytomegalovirus infection;Cellular senescence;Human T-cell leukemia virus 1 infection;Cushing syndrome;Viral carcinogenesis;Cell cycle;p53 signaling pathway,GO_Biological_Process_2023;KEGG_2021_Human
BRCA1,17,GO_Biological_Process_2023:Regulation Of Cell Growth (GO:0001558);GO_Biological_Process_2023:Negative Regulation Of Cell Cycle (GO:0045786);GO_Biological_Process_2023:Response To Ionizing Radiation (GO:0010212);GO_Biological_Process_2023:Regulation Of Cell Cycle (GO:0051726);GO_Biological_Process_2023:Cellular Response To Radiation (GO:0071478);GO_Biological_Process_2023:Negative Regulation Of Cell Growth (GO:0030308);GO_Biological_Process_2023:Negative Regulation Of Growth (GO:0045926);GO_Biological_Process_2023:Cellular Response To Ionizing Radiation (GO:0071479);GO_Biological_Process_2023:Positive Regulation Of Gene Expression (GO:0010628);GO_Biological_Process_2023:Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);GO_Biological_Process_2023:Negative Regulation Of Cellular Process (GO:0048523);GO_Biological_Process_2023:Positive Regulation Of DNA Metabolic Process (GO:0051054);GO_Molecular_Function_2023:Ubiquitin Protein Ligase Binding (GO:0031625);GO_Molecular_Function_2023:Ubiquitin-Like Protein Ligase Binding (GO:0044389);KEGG_2021_Human:Breast cancer;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:PI3K-Akt signaling pathway,Regulation Of Cell Growth (GO:0001558);Negative Regulation Of Cell Cycle (GO:0045786);Response To Ionizing Radiation (GO:0010212);Regulation Of Cell Cycle (GO:0051726);Cellular Response To Radiation (GO:0071478);Negative Regulation Of Cell Growth (GO:0030308);Negative Regulation Of Growth (GO:0045926);Cellular Response To Ionizing Radiation (GO:0071479);Positive Regulation Of Gene Expression (GO:0010628);Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);Negative Regulation Of Cellular Process (GO:0048523);Positive Regulation Of DNA Metabolic Process (GO:0051054);Ubiquitin Protein Ligase Binding (GO:0031625);Ubiquitin-Like Protein Ligase Binding (GO:0044389);Breast cancer;MicroRNAs in cancer;PI3K-Akt signaling pathway,GO_Biological_Process_2023;GO_Molecular_Function_2023;KEGG_2021_Human
TP53,69,GO_Biological_Process_2023:Regulation Of Cell Growth (GO:0001558);GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Response To Ionizing Radiation (GO:0010212);GO_Biological_Process_2023:Negative Regulation Of Apoptotic Process (GO:0043066);GO_Biological_Process_2023:Negative Regulation Of Programmed Cell Death (GO:0043069);GO_Biological_Process_2023:Regulation Of Apoptotic Process (GO:0042981);GO_Biological_Process_2023:Regulation Of Cell Cycle (GO:0051726);GO_Biological_Process_2023:Positive Regulation Of miRNA Transcription (GO:1902895);GO_Biological_Process_2023:Regulation Of Fibroblast Proliferation (GO:0048145);GO_Biological_Process_2023:Small GTPase Mediated Signal Transduction (GO:0007264);GO_Biological_Process_2023:Cellular Response To Radiation (GO:0071478);GO_Biological_Process_2023:Positive Regulation Of miRNA Metabolic Process (GO:2000630);GO_Biological_Process_2023:Negative Regulation Of Cell Growth (GO:0030308);GO_Biological_Process_2023:Negative Regulation Of Growth (GO:0045926);GO_Biological_Process_2023:Cellular Response To Ionizing Radiation (GO:0071479);GO_Biological_Process_2023:Positive Regulation Of Gene Expression (GO:0010628);GO_Biological_Process_2023:Regulation Of miRNA Transcription (GO:1902893);GO_Biological_Process_2023:Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);GO_Biological_Process_2023:Ras Protein Signal Transduction (GO:0007265);GO_Biological_Process_2023:Positive Regulation Of Protein Phosphorylation (GO:0001934);GO_Biological_Process_2023:Negative Regulation Of Cellular Process (GO:0048523);GO_Biological_Process_2023:Cellular Response To Hypoxia (GO:0071456);GO_Biological_Process_2023:Cellular Response To Decreased Oxygen Levels (GO:0036294);GO_Biological_Process_2023:Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730);GO_Biological_Process_2023:Response To UV (GO:0009411);GO_Molecular_Function_2023:Protein Phosphatase Binding (GO:0019903);GO_Molecular_Function_2023:Ubiquitin Protein Ligase Binding (GO:0031625);GO_Molecular_Function_2023:Ubiquitin-Like Protein Ligase Binding (GO:0044389);KEGG_2021_Human:Bladder cancer;KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Melanoma;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Endometrial cancer;KEGG_2021_Human:Glioma;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Gastric cancer;KEGG_2021_Human:Central carbon metabolism in cancer;KEGG_2021_Human:Chronic myeloid leukemia;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:Prostate cancer;KEGG_2021_Human:Colorectal cancer;KEGG_2021_Human:PI3K-Akt signaling pathway;KEGG_2021_Human:Proteoglycans in cancer;KEGG_2021_Human:Human cytomegalovirus infection;KEGG_2021_Human:Cellular senescence;KEGG_2021_Human:Hepatitis C;KEGG_2021_Human:Human T-cell leukemia virus 1 infection;KEGG_2021_Human:Small cell lung cancer;KEGG_2021_Human:Human papillomavirus infection;KEGG_2021_Human:Kaposi sarcoma-associated herpesvirus infection;KEGG_2021_Human:MAPK signaling pathway;KEGG_2021_Human:Thyroid cancer;KEGG_2021_Human:Hepatitis B;KEGG_2021_Human:Viral carcinogenesis;KEGG_2021_Human:Cell cycle;KEGG_2021_Human:p53 signaling pathway;KEGG_2021_Human:Epstein-Barr virus infection;KEGG_2021_Human:Neurotrophin signaling pathway;KEGG_2021_Human:Sphingolipid signaling pathway;KEGG_2021_Human:Thyroid hormone signaling pathway;KEGG_2021_Human:Longevity regulating pathway;KEGG_2021_Human:Measles;KEGG_2021_Human:Fluid shear stress and atherosclerosis;KEGG_2021_Human:Apoptosis;KEGG_2021_Human:Wnt signaling pathway;KEGG_2021_Human:Transcriptional misregulation in cancer;KEGG_2021_Human:Lipid and atherosclerosis,Regulation Of Cell Growth (GO:0001558);Regulation Of Cell Population Proliferation (GO:0042127);Response To Ionizing Radiation (GO:0010212);Negative Regulation Of Apoptotic Process (GO:0043066);Negative Regulation Of Programmed Cell Death (GO:0043069);Regulation Of Apoptotic Process (GO:0042981);Regulation Of Cell Cycle (GO:0051726);Positive Regulation Of miRNA Transcription (GO:1902895);Regulation Of Fibroblast Proliferation (GO:0048145);Small GTPase Mediated Signal Transduction (GO:0007264);Cellular Response To Radiation (GO:0071478);Positive Regulation Of miRNA Metabolic Process (GO:2000630);Negative Regulation Of Cell Growth (GO:0030308);Negative Regulation Of Growth (GO:0045926);Cellular Response To Ionizing Radiation (GO:0071479);Positive Regulation Of Gene Expression (GO:0010628);Regulation Of miRNA Transcription (GO:1902893);Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);Ras Protein Signal Transduction (GO:0007265);Positive Regulation Of Protein Phosphorylation (GO:0001934);Negative Regulation Of Cellular Process (GO:0048523);Cellular Response To Hypoxia (GO:0071456);Cellular Response To Decreased Oxygen Levels (GO:0036294);Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730);Response To UV (GO:0009411);Protein Phosphatase Binding (GO:0019903);Ubiquitin Protein Ligase Binding (GO:0031625);Ubiquitin-Like Protein Ligase Binding (GO:0044389);Bladder cancer;Non-small cell lung cancer;Pancreatic cancer;Breast cancer;Melanoma;Hepatocellular carcinoma;Endometrial cancer;Glioma;Pathways in cancer;Gastric cancer;Central carbon metabolism in cancer;Chronic myeloid leukemia;MicroRNAs in cancer;Prostate cancer;Colorectal cancer;PI3K-Akt signaling pathway;Proteoglycans in cancer;Human cytomegalovirus infection;Cellular senescence;Hepatitis C;Human T-cell leukemia virus 1 infection;Small cell lung cancer;Human papillomavirus infection;Kaposi sarcoma-associated herpesvirus infection;MAPK signaling pathway;Thyroid cancer;Hepatitis B;Viral carcinogenesis;Cell cycle;p53 signaling pathway;Epstein-Barr virus infection;Neurotrophin signaling pathway;Sphingolipid signaling pathway;Thyroid hormone signaling pathway;Longevity regulating pathway;Measles;Fluid shear stress and atherosclerosis;Apoptosis;Wnt signaling pathway;Transcriptional misregulation in cancer;Lipid and atherosclerosis,GO_Biological_Process_2023;GO_Molecular_Function_2023;KEGG_2021_Human
APC,27,GO_Biological_Process_2023:Negative Regulation Of Cell Cycle (GO:0045786);GO_Biological_Process_2023:Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045);GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079);GO_Biological_Process_2023:Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901);GO_Biological_Process_2023:Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134);GO_Biological_Process_2023:Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807);GO_Biological_Process_2023:Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991);GO_Biological_Process_2023:Regulation Of Apoptotic Process (GO:0042981);GO_Biological_Process_2023:Negative Regulation Of Cellular Process (GO:0048523);GO_Biological_Process_2023:Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806);GO_Biological_Process_2023:Nervous System Development (GO:0007399);GO_Molecular_Function_2023:Ubiquitin Protein Ligase Binding (GO:0031625);GO_Molecular_Function_2023:Ubiquitin-Like Protein Ligase Binding (GO:0044389);KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Endometrial cancer;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Gastric cancer;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:Colorectal cancer;KEGG_2021_Human:Human papillomavirus infection;KEGG_2021_Human:Cushing syndrome;KEGG_2021_Human:Regulation of actin cytoskeleton;KEGG_2021_Human:Signaling pathways regulating pluripotency of stem cells;KEGG_2021_Human:Wnt signaling pathway;KEGG_2021_Human:Alzheimer disease,Negative Regulation Of Cell Cycle (GO:0045786);Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045);Regulation Of Cell Population Proliferation (GO:0042127);Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079);Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901);Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134);Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807);Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991);Regulation Of Apoptotic Process (GO:0042981);Negative Regulation Of Cellular Process (GO:0048523);Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806);Nervous System Development (GO:0007399);Ubiquitin Protein Ligase Binding (GO:0031625);Ubiquitin-Like Protein Ligase Binding (GO:0044389);Breast cancer;Hepatocellular carcinoma;Endometrial cancer;Pathways in cancer;Gastric cancer;MicroRNAs in cancer;Colorectal cancer;Human papillomavirus infection;Cushing syndrome;Regulation of actin cytoskeleton;Signaling pathways regulating pluripotency of stem cells;Wnt signaling pathway;Alzheimer disease,GO_Biological_Process_2023;GO_Molecular_Function_2023;KEGG_2021_Human
PTEN,40,GO_Biological_Process_2023:Negative Regulation Of Cell Cycle (GO:0045786);GO_Biological_Process_2023:Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045);GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079);GO_Biological_Process_2023:Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901);GO_Biological_Process_2023:Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134);GO_Biological_Process_2023:Phosphatidylinositol 3-Kinase Signaling (GO:0014065);GO_Biological_Process_2023:Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807);GO_Biological_Process_2023:Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135);GO_Biological_Process_2023:Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991);GO_Biological_Process_2023:Positive Regulation Of Cell Population Proliferation (GO:0008284);GO_Biological_Process_2023:Phosphatidylinositol-Mediated Signaling (GO:0048015);GO_Biological_Process_2023:Regulation Of ERK1 And ERK2 Cascade (GO:0070372);GO_Biological_Process_2023:Negative Regulation Of Cellular Process (GO:0048523);GO_Biological_Process_2023:Regulation Of Protein Phosphorylation (GO:0001932);GO_Biological_Process_2023:Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806);GO_Biological_Process_2023:Nervous System Development (GO:0007399);GO_Biological_Process_2023:Positive Regulation Of Cellular Process (GO:0048522);GO_Biological_Process_2023:Negative Regulation Of Multicellular Organismal Process (GO:0051241);KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Melanoma;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Endometrial cancer;KEGG_2021_Human:Glioma;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Central carbon metabolism in cancer;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:Prostate cancer;KEGG_2021_Human:PI3K-Akt signaling pathway;KEGG_2021_Human:Cellular senescence;KEGG_2021_Human:PD-L1 expression and PD-1 checkpoint pathway in cancer;KEGG_2021_Human:Human T-cell leukemia virus 1 infection;KEGG_2021_Human:Small cell lung cancer;KEGG_2021_Human:Human papillomavirus infection;KEGG_2021_Human:Focal adhesion;KEGG_2021_Human:FoxO signaling pathway;KEGG_2021_Human:p53 signaling pathway;KEGG_2021_Human:Sphingolipid signaling pathway;KEGG_2021_Human:mTOR signaling pathway;KEGG_2021_Human:Autophagy,Negative Regulation Of Cell Cycle (GO:0045786);Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045);Regulation Of Cell Population Proliferation (GO:0042127);Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079);Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901);Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134);Phosphatidylinositol 3-Kinase Signaling (GO:0014065);Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807);Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135);Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991);Positive Regulation Of Cell Population Proliferation (GO:0008284);Phosphatidylinositol-Mediated Signaling (GO:0048015);Regulation Of ERK1 And ERK2 Cascade (GO:0070372);Negative Regulation Of Cellular Process (GO:0048523);Regulation Of Protein Phosphorylation (GO:0001932);Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806);Nervous System Development (GO:0007399);Positive Regulation Of Cellular Process (GO:0048522);Negative Regulation Of Multicellular Organismal Process (GO:0051241);Breast cancer;Melanoma;Hepatocellular carcinoma;Endometrial cancer;Glioma;Pathways in cancer;Central carbon metabolism in cancer;MicroRNAs in cancer;Prostate cancer;PI3K-Akt signaling pathway;Cellular senescence;PD-L1 expression and PD-1 checkpoint pathway in cancer;Human T-cell leukemia virus 1 infection;Small cell lung cancer;Human papillomavirus infection;Focal adhesion;FoxO signaling pathway;p53 signaling pathway;Sphingolipid signaling pathway;mTOR signaling pathway;Autophagy,GO_Biological_Process_2023;KEGG_2021_Human
KRAS,70,GO_Biological_Process_2023:Positive Regulation Of Phosphorylation (GO:0042327);GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Small GTPase Mediated Signal Transduction (GO:0007264);GO_Biological_Process_2023:Positive Regulation Of Gene Expression (GO:0010628);GO_Biological_Process_2023:Positive Regulation Of Cell Population Proliferation (GO:0008284);GO_Biological_Process_2023:Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);GO_Biological_Process_2023:Ras Protein Signal Transduction (GO:0007265);GO_Biological_Process_2023:Positive Regulation Of Protein Phosphorylation (GO:0001934);GO_Biological_Process_2023:Regulation Of Protein Phosphorylation (GO:0001932);GO_Biological_Process_2023:Positive Regulation Of Cellular Process (GO:0048522);GO_Biological_Process_2023:MAPK Cascade (GO:0000165);GO_Biological_Process_2023:Positive Regulation Of Protein Modification Process (GO:0031401);KEGG_2021_Human:Bladder cancer;KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Melanoma;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Endometrial cancer;KEGG_2021_Human:Glioma;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Gastric cancer;KEGG_2021_Human:Central carbon metabolism in cancer;KEGG_2021_Human:Chronic myeloid leukemia;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:Prostate cancer;KEGG_2021_Human:Colorectal cancer;KEGG_2021_Human:PI3K-Akt signaling pathway;KEGG_2021_Human:Proteoglycans in cancer;KEGG_2021_Human:Human cytomegalovirus infection;KEGG_2021_Human:Cellular senescence;KEGG_2021_Human:Hepatitis C;KEGG_2021_Human:ErbB signaling pathway;KEGG_2021_Human:PD-L1 expression and PD-1 checkpoint pathway in cancer;KEGG_2021_Human:Human T-cell leukemia virus 1 infection;KEGG_2021_Human:Human papillomavirus infection;KEGG_2021_Human:Kaposi sarcoma-associated herpesvirus infection;KEGG_2021_Human:Renal cell carcinoma;KEGG_2021_Human:MAPK signaling pathway;KEGG_2021_Human:Thyroid cancer;KEGG_2021_Human:Hepatitis B;KEGG_2021_Human:Viral carcinogenesis;KEGG_2021_Human:Rap1 signaling pathway;KEGG_2021_Human:FoxO signaling pathway;KEGG_2021_Human:Acute myeloid leukemia;KEGG_2021_Human:Chemical carcinogenesis;KEGG_2021_Human:AGE-RAGE signaling pathway in diabetic complications;KEGG_2021_Human:T cell receptor signaling pathway;KEGG_2021_Human:Neurotrophin signaling pathway;KEGG_2021_Human:Sphingolipid signaling pathway;KEGG_2021_Human:Thyroid hormone signaling pathway;KEGG_2021_Human:Regulation of actin cytoskeleton;KEGG_2021_Human:Relaxin signaling pathway;KEGG_2021_Human:Ras signaling pathway;KEGG_2021_Human:VEGF signaling pathway;KEGG_2021_Human:Signaling pathways regulating pluripotency of stem cells;KEGG_2021_Human:mTOR signaling pathway;KEGG_2021_Human:Choline metabolism in cancer;KEGG_2021_Human:Progesterone-mediated oocyte maturation;KEGG_2021_Human:Longevity regulating pathway;KEGG_2021_Human:Natural killer cell mediated cytotoxicity;KEGG_2021_Human:Autophagy;KEGG_2021_Human:Estrogen signaling pathway;KEGG_2021_Human:Insulin signaling pathway;KEGG_2021_Human:Apoptosis;KEGG_2021_Human:Phospholipase D signaling pathway;KEGG_2021_Human:Axon guidance;KEGG_2021_Human:Chemokine signaling pathway;KEGG_2021_Human:Alzheimer disease;KEGG_2021_Human:Lipid and atherosclerosis,Positive Regulation Of Phosphorylation (GO:0042327);Regulation Of Cell Population Proliferation (GO:0042127);Small GTPase Mediated Signal Transduction (GO:0007264);Positive Regulation Of Gene Expression (GO:0010628);Positive Regulation Of Cell Population Proliferation (GO:0008284);Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);Ras Protein Signal Transduction (GO:0007265);Positive Regulation Of Protein Phosphorylation (GO:0001934);Regulation Of Protein Phosphorylation (GO:0001932);Positive Regulation Of Cellular Process (GO:0048522);MAPK Cascade (GO:0000165);Positive Regulation Of Protein Modification Process (GO:0031401);Bladder cancer;Non-small cell lung cancer;Pancreatic cancer;Breast cancer;Melanoma;Hepatocellular carcinoma;Endometrial cancer;Glioma;Pathways in cancer;Gastric cancer;Central carbon metabolism in cancer;Chronic myeloid leukemia;MicroRNAs in cancer;Prostate cancer;Colorectal cancer;PI3K-Akt signaling pathway;Proteoglycans in cancer;Human cytomegalovirus infection;Cellular senescence;Hepatitis C;ErbB signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;Human T-cell leukemia virus 1 infection;Human papillomavirus infection;Kaposi sarcoma-associated herpesvirus infection;Renal cell carcinoma;MAPK signaling pathway;Thyroid cancer;Hepatitis B;Viral carcinogenesis;Rap1 signaling pathway;FoxO signaling pathway;Acute myeloid leukemia;Chemical carcinogenesis;AGE-RAGE signaling pathway in diabetic complications;T cell receptor signaling pathway;Neurotrophin signaling pathway;Sphingolipid signaling pathway;Thyroid hormone signaling pathway;Regulation of actin cytoskeleton;Relaxin signaling pathway;Ras signaling pathway;VEGF signaling pathway;Signaling pathways regulating pluripotency of stem cells;mTOR signaling pathway;Choline metabolism in cancer;Progesterone-mediated oocyte maturation;Longevity regulating pathway;Natural killer cell mediated cytotoxicity;Autophagy;Estrogen signaling pathway;Insulin signaling pathway;Apoptosis;Phospholipase D signaling pathway;Axon guidance;Chemokine signaling pathway;Alzheimer disease;Lipid and atherosclerosis,GO_Biological_Process_2023;KEGG_2021_Human
VEGFA,47,GO_Biological_Process_2023:Positive Regulation Of Phosphorylation (GO:0042327);GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);GO_Biological_Process_2023:Negative Regulation Of Apoptotic Process (GO:0043066);GO_Biological_Process_2023:Negative Regulation Of Programmed Cell Death (GO:0043069);GO_Biological_Process_2023:Regulation Of Epithelial Cell Proliferation (GO:0050678);GO_Biological_Process_2023:Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135);GO_Biological_Process_2023:Branching Morphogenesis Of An Epithelial Tube (GO:0048754);GO_Biological_Process_2023:Regulation Of Apoptotic Process (GO:0042981);GO_Biological_Process_2023:Positive Regulation Of Epithelial Cell Proliferation (GO:0050679);GO_Biological_Process_2023:Positive Regulation Of Gene Expression (GO:0010628);GO_Biological_Process_2023:Positive Regulation Of Cell Population Proliferation (GO:0008284);GO_Biological_Process_2023:Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);GO_Biological_Process_2023:Positive Regulation Of Protein Phosphorylation (GO:0001934);GO_Biological_Process_2023:Regulation Of Protein Phosphorylation (GO:0001932);GO_Biological_Process_2023:Cellular Response To Hypoxia (GO:0071456);GO_Biological_Process_2023:Cellular Response To Decreased Oxygen Levels (GO:0036294);GO_Biological_Process_2023:Neuron Differentiation (GO:0030182);GO_Biological_Process_2023:Nervous System Development (GO:0007399);GO_Biological_Process_2023:Positive Regulation Of Cellular Process (GO:0048522);GO_Biological_Process_2023:Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138);GO_Biological_Process_2023:Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730);GO_Biological_Process_2023:Positive Regulation Of MAP Kinase Activity (GO:0043406);GO_Biological_Process_2023:Positive Regulation Of Protein Modification Process (GO:0031401);GO_Biological_Process_2023:Regulation Of MAP Kinase Activity (GO:0043405);GO_Biological_Process_2023:Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902);KEGG_2021_Human:Bladder cancer;KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:PI3K-Akt signaling pathway;KEGG_2021_Human:Proteoglycans in cancer;KEGG_2021_Human:Human cytomegalovirus infection;KEGG_2021_Human:Human papillomavirus infection;KEGG_2021_Human:Kaposi sarcoma-associated herpesvirus infection;KEGG_2021_Human:Renal cell carcinoma;KEGG_2021_Human:Focal adhesion;KEGG_2021_Human:MAPK signaling pathway;KEGG_2021_Human:Rap1 signaling pathway;KEGG_2021_Human:Chemical carcinogenesis;KEGG_2021_Human:AGE-RAGE signaling pathway in diabetic complications;KEGG_2021_Human:HIF-1 signaling pathway;KEGG_2021_Human:Relaxin signaling pathway;KEGG_2021_Human:Ras signaling pathway;KEGG_2021_Human:VEGF signaling pathway;KEGG_2021_Human:Calcium signaling pathway;KEGG_2021_Human:Fluid shear stress and atherosclerosis,Positive Regulation Of Phosphorylation (GO:0042327);Regulation Of Cell Population Proliferation (GO:0042127);Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);Negative Regulation Of Apoptotic Process (GO:0043066);Negative Regulation Of Programmed Cell Death (GO:0043069);Regulation Of Epithelial Cell Proliferation (GO:0050678);Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135);Branching Morphogenesis Of An Epithelial Tube (GO:0048754);Regulation Of Apoptotic Process (GO:0042981);Positive Regulation Of Epithelial Cell Proliferation (GO:0050679);Positive Regulation Of Gene Expression (GO:0010628);Positive Regulation Of Cell Population Proliferation (GO:0008284);Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);Positive Regulation Of Protein Phosphorylation (GO:0001934);Regulation Of Protein Phosphorylation (GO:0001932);Cellular Response To Hypoxia (GO:0071456);Cellular Response To Decreased Oxygen Levels (GO:0036294);Neuron Differentiation (GO:0030182);Nervous System Development (GO:0007399);Positive Regulation Of Cellular Process (GO:0048522);Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138);Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730);Positive Regulation Of MAP Kinase Activity (GO:0043406);Positive Regulation Of Protein Modification Process (GO:0031401);Regulation Of MAP Kinase Activity (GO:0043405);Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902);Bladder cancer;Pancreatic cancer;Pathways in cancer;MicroRNAs in cancer;PI3K-Akt signaling pathway;Proteoglycans in cancer;Human cytomegalovirus infection;Human papillomavirus infection;Kaposi sarcoma-associated herpesvirus infection;Renal cell carcinoma;Focal adhesion;MAPK signaling pathway;Rap1 signaling pathway;Chemical carcinogenesis;AGE-RAGE signaling pathway in diabetic complications;HIF-1 signaling pathway;Relaxin signaling pathway;Ras signaling pathway;VEGF signaling pathway;Calcium signaling pathway;Fluid shear stress and atherosclerosis,GO_Biological_Process_2023;KEGG_2021_Human
PIK3CA,69,GO_Biological_Process_2023:Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173);GO_Biological_Process_2023:Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);GO_Biological_Process_2023:Negative Regulation Of Apoptotic Process (GO:0043066);GO_Biological_Process_2023:Phosphatidylinositol 3-Kinase Signaling (GO:0014065);GO_Biological_Process_2023:ERBB Signaling Pathway (GO:0038127);GO_Biological_Process_2023:Phosphatidylinositol-Mediated Signaling (GO:0048015);GO_Biological_Process_2023:Phosphorylation (GO:0016310);KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Melanoma;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Endometrial cancer;KEGG_2021_Human:Glioma;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Gastric cancer;KEGG_2021_Human:Central carbon metabolism in cancer;KEGG_2021_Human:Chronic myeloid leukemia;KEGG_2021_Human:MicroRNAs in cancer;KEGG_2021_Human:Prostate cancer;KEGG_2021_Human:Colorectal cancer;KEGG_2021_Human:PI3K-Akt signaling pathway;KEGG_2021_Human:Proteoglycans in cancer;KEGG_2021_Human:Human cytomegalovirus infection;KEGG_2021_Human:Cellular senescence;KEGG_2021_Human:Hepatitis C;KEGG_2021_Human:ErbB signaling pathway;KEGG_2021_Human:PD-L1 expression and PD-1 checkpoint pathway in cancer;KEGG_2021_Human:Human T-cell leukemia virus 1 infection;KEGG_2021_Human:Small cell lung cancer;KEGG_2021_Human:Human papillomavirus infection;KEGG_2021_Human:Kaposi sarcoma-associated herpesvirus infection;KEGG_2021_Human:Renal cell carcinoma;KEGG_2021_Human:Focal adhesion;KEGG_2021_Human:Hepatitis B;KEGG_2021_Human:Viral carcinogenesis;KEGG_2021_Human:Rap1 signaling pathway;KEGG_2021_Human:FoxO signaling pathway;KEGG_2021_Human:Acute myeloid leukemia;KEGG_2021_Human:Chemical carcinogenesis;KEGG_2021_Human:AGE-RAGE signaling pathway in diabetic complications;KEGG_2021_Human:T cell receptor signaling pathway;KEGG_2021_Human:HIF-1 signaling pathway;KEGG_2021_Human:Epstein-Barr virus infection;KEGG_2021_Human:Neurotrophin signaling pathway;KEGG_2021_Human:Sphingolipid signaling pathway;KEGG_2021_Human:Thyroid hormone signaling pathway;KEGG_2021_Human:Regulation of actin cytoskeleton;KEGG_2021_Human:Relaxin signaling pathway;KEGG_2021_Human:Ras signaling pathway;KEGG_2021_Human:VEGF signaling pathway;KEGG_2021_Human:Signaling pathways regulating pluripotency of stem cells;KEGG_2021_Human:mTOR signaling pathway;KEGG_2021_Human:Choline metabolism in cancer;KEGG_2021_Human:Progesterone-mediated oocyte maturation;KEGG_2021_Human:Longevity regulating pathway;KEGG_2021_Human:Natural killer cell mediated cytotoxicity;KEGG_2021_Human:Autophagy;KEGG_2021_Human:Estrogen signaling pathway;KEGG_2021_Human:Insulin signaling pathway;KEGG_2021_Human:Measles;KEGG_2021_Human:Fluid shear stress and atherosclerosis;KEGG_2021_Human:Apoptosis;KEGG_2021_Human:Phospholipase D signaling pathway;KEGG_2021_Human:JAK-STAT signaling pathway;KEGG_2021_Human:Axon guidance;KEGG_2021_Human:Chemokine signaling pathway;KEGG_2021_Human:Alzheimer disease;KEGG_2021_Human:Lipid and atherosclerosis,Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173);Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169);Negative Regulation Of Apoptotic Process (GO:0043066);Phosphatidylinositol 3-Kinase Signaling (GO:0014065);ERBB Signaling Pathway (GO:0038127);Phosphatidylinositol-Mediated Signaling (GO:0048015);Phosphorylation (GO:0016310);Non-small cell lung cancer;Pancreatic cancer;Breast cancer;Melanoma;Hepatocellular carcinoma;Endometrial cancer;Glioma;Pathways in cancer;Gastric cancer;Central carbon metabolism in cancer;Chronic myeloid leukemia;MicroRNAs in cancer;Prostate cancer;Colorectal cancer;PI3K-Akt signaling pathway;Proteoglycans in cancer;Human cytomegalovirus infection;Cellular senescence;Hepatitis C;ErbB signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;Human T-cell leukemia virus 1 infection;Small cell lung cancer;Human papillomavirus infection;Kaposi sarcoma-associated herpesvirus infection;Renal cell carcinoma;Focal adhesion;Hepatitis B;Viral carcinogenesis;Rap1 signaling pathway;FoxO signaling pathway;Acute myeloid leukemia;Chemical carcinogenesis;AGE-RAGE signaling pathway in diabetic complications;T cell receptor signaling pathway;HIF-1 signaling pathway;Epstein-Barr virus infection;Neurotrophin signaling pathway;Sphingolipid signaling pathway;Thyroid hormone signaling pathway;Regulation of actin cytoskeleton;Relaxin signaling pathway;Ras signaling pathway;VEGF signaling pathway;Signaling pathways regulating pluripotency of stem cells;mTOR signaling pathway;Choline metabolism in cancer;Progesterone-mediated oocyte maturation;Longevity regulating pathway;Natural killer cell mediated cytotoxicity;Autophagy;Estrogen signaling pathway;Insulin signaling pathway;Measles;Fluid shear stress and atherosclerosis;Apoptosis;Phospholipase D signaling pathway;JAK-STAT signaling pathway;Axon guidance;Chemokine signaling pathway;Alzheimer disease;Lipid and atherosclerosis,GO_Biological_Process_2023;KEGG_2021_Human
BRAF,47,GO_Biological_Process_2023:Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173);GO_Biological_Process_2023:Negative Regulation Of Apoptotic Process (GO:0043066);GO_Biological_Process_2023:Negative Regulation Of Programmed Cell Death (GO:0043069);GO_Biological_Process_2023:Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135);GO_Biological_Process_2023:Regulation Of Apoptotic Process (GO:0042981);GO_Biological_Process_2023:ERBB Signaling Pathway (GO:0038127);GO_Biological_Process_2023:Positive Regulation Of Gene Expression (GO:0010628);GO_Biological_Process_2023:Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);GO_Biological_Process_2023:Regulation Of ERK1 And ERK2 Cascade (GO:0070372);GO_Biological_Process_2023:Positive Regulation Of Protein Phosphorylation (GO:0001934);GO_Biological_Process_2023:Phosphorylation (GO:0016310);GO_Biological_Process_2023:Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138);GO_Biological_Process_2023:MAPK Cascade (GO:0000165);GO_Biological_Process_2023:Protein Phosphorylation (GO:0006468);KEGG_2021_Human:Bladder cancer;KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Melanoma;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Endometrial cancer;KEGG_2021_Human:Glioma;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Gastric cancer;KEGG_2021_Human:Chronic myeloid leukemia;KEGG_2021_Human:Prostate cancer;KEGG_2021_Human:Colorectal cancer;KEGG_2021_Human:Proteoglycans in cancer;KEGG_2021_Human:Hepatitis C;KEGG_2021_Human:ErbB signaling pathway;KEGG_2021_Human:Renal cell carcinoma;KEGG_2021_Human:Focal adhesion;KEGG_2021_Human:MAPK signaling pathway;KEGG_2021_Human:Thyroid cancer;KEGG_2021_Human:Cushing syndrome;KEGG_2021_Human:Hepatitis B;KEGG_2021_Human:Rap1 signaling pathway;KEGG_2021_Human:FoxO signaling pathway;KEGG_2021_Human:Acute myeloid leukemia;KEGG_2021_Human:Neurotrophin signaling pathway;KEGG_2021_Human:Regulation of actin cytoskeleton;KEGG_2021_Human:mTOR signaling pathway;KEGG_2021_Human:Progesterone-mediated oocyte maturation;KEGG_2021_Human:Natural killer cell mediated cytotoxicity;KEGG_2021_Human:Insulin signaling pathway;KEGG_2021_Human:Chemokine signaling pathway;KEGG_2021_Human:Alzheimer disease,Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173);Negative Regulation Of Apoptotic Process (GO:0043066);Negative Regulation Of Programmed Cell Death (GO:0043069);Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135);Regulation Of Apoptotic Process (GO:0042981);ERBB Signaling Pathway (GO:0038127);Positive Regulation Of Gene Expression (GO:0010628);Positive Regulation Of Macromolecule Metabolic Process (GO:0010604);Regulation Of ERK1 And ERK2 Cascade (GO:0070372);Positive Regulation Of Protein Phosphorylation (GO:0001934);Phosphorylation (GO:0016310);Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138);MAPK Cascade (GO:0000165);Protein Phosphorylation (GO:0006468);Bladder cancer;Non-small cell lung cancer;Pancreatic cancer;Breast cancer;Melanoma;Hepatocellular carcinoma;Endometrial cancer;Glioma;Pathways in cancer;Gastric cancer;Chronic myeloid leukemia;Prostate cancer;Colorectal cancer;Proteoglycans in cancer;Hepatitis C;ErbB signaling pathway;Renal cell carcinoma;Focal adhesion;MAPK signaling pathway;Thyroid cancer;Cushing syndrome;Hepatitis B;Rap1 signaling pathway;FoxO signaling pathway;Acute myeloid leukemia;Neurotrophin signaling pathway;Regulation of actin cytoskeleton;mTOR signaling pathway;Progesterone-mediated oocyte maturation;Natural killer cell mediated cytotoxicity;Insulin signaling pathway;Chemokine signaling pathway;Alzheimer disease,GO_Biological_Process_2023;KEGG_2021_Human
CDK4,33,GO_Biological_Process_2023:Regulation Of Cell Population Proliferation (GO:0042127);GO_Biological_Process_2023:Regulation Of Cell Cycle (GO:0051726);GO_Biological_Process_2023:Regulation Of Fibroblast Proliferation (GO:0048145);GO_Biological_Process_2023:Positive Regulation Of Cell Population Proliferation (GO:0008284);GO_Biological_Process_2023:Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992);GO_Biological_Process_2023:Phosphorylation (GO:0016310);GO_Biological_Process_2023:Positive Regulation Of Cellular Process (GO:0048522);GO_Biological_Process_2023:Protein Phosphorylation (GO:0006468);KEGG_2021_Human:Bladder cancer;KEGG_2021_Human:Non-small cell lung cancer;KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Melanoma;KEGG_2021_Human:Hepatocellular carcinoma;KEGG_2021_Human:Glioma;KEGG_2021_Human:Pathways in cancer;KEGG_2021_Human:Chronic myeloid leukemia;KEGG_2021_Human:PI3K-Akt signaling pathway;KEGG_2021_Human:Human cytomegalovirus infection;KEGG_2021_Human:Cellular senescence;KEGG_2021_Human:Hepatitis C;KEGG_2021_Human:Human T-cell leukemia virus 1 infection;KEGG_2021_Human:Small cell lung cancer;KEGG_2021_Human:Human papillomavirus infection;KEGG_2021_Human:Kaposi sarcoma-associated herpesvirus infection;KEGG_2021_Human:Cushing syndrome;KEGG_2021_Human:Viral carcinogenesis;KEGG_2021_Human:Cell cycle;KEGG_2021_Human:p53 signaling pathway;KEGG_2021_Human:AGE-RAGE signaling pathway in diabetic complications;KEGG_2021_Human:T cell receptor signaling pathway;KEGG_2021_Human:Epstein-Barr virus infection;KEGG_2021_Human:Measles,Regulation Of Cell Population Proliferation (GO:0042127);Regulation Of Cell Cycle (GO:0051726);Regulation Of Fibroblast Proliferation (GO:0048145);Positive Regulation Of Cell Population Proliferation (GO:0008284);Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992);Phosphorylation (GO:0016310);Positive Regulation Of Cellular Process (GO:0048522);Protein Phosphorylation (GO:0006468);Bladder cancer;Non-small cell lung cancer;Pancreatic cancer;Breast cancer;Melanoma;Hepatocellular carcinoma;Glioma;Pathways in cancer;Chronic myeloid leukemia;PI3K-Akt signaling pathway;Human cytomegalovirus infection;Cellular senescence;Hepatitis C;Human T-cell leukemia virus 1 infection;Small cell lung cancer;Human papillomavirus infection;Kaposi sarcoma-associated herpesvirus infection;Cushing syndrome;Viral carcinogenesis;Cell cycle;p53 signaling pathway;AGE-RAGE signaling pathway in diabetic complications;T cell receptor signaling pathway;Epstein-Barr virus infection;Measles,GO_Biological_Process_2023;KEGG_2021_Human
BRCA2,7,GO_Biological_Process_2023:Response To Ionizing Radiation (GO:0010212);GO_Biological_Process_2023:Cellular Response To Radiation (GO:0071478);GO_Biological_Process_2023:Cellular Response To Ionizing Radiation (GO:0071479);GO_Biological_Process_2023:Negative Regulation Of Multicellular Organismal Process (GO:0051241);KEGG_2021_Human:Pancreatic cancer;KEGG_2021_Human:Breast cancer;KEGG_2021_Human:Pathways in cancer,Response To Ionizing Radiation (GO:0010212);Cellular Response To Radiation (GO:0071478);Cellular Response To Ionizing Radiation (GO:0071479);Negative Regulation Of Multicellular Organismal Process (GO:0051241);Pancreatic cancer;Breast cancer;Pathways in cancer,GO_Biological_Process_2023;KEGG_2021_Human
CTLA4,2,GO_Biological_Process_2023:Regulation Of Apoptotic Process (GO:0042981);KEGG_2021_Human:T cell receptor signaling pathway,Regulation Of Apoptotic Process (GO:0042981);T cell receptor signaling pathway,GO_Biological_Process_2023;KEGG_2021_Human
CD274,1,KEGG_2021_Human:PD-L1 expression and PD-1 checkpoint pathway in cancer,PD-L1 expression and PD-1 checkpoint pathway in cancer,KEGG_2021_Human
